医药代表-心血管代谢健康事业部 at Eli Lilly and Company

Shanghai, Shanghai, China

Eli Lilly and Company Logo
Not SpecifiedCompensation
Junior (1 to 2 years), Mid-level (3 to 4 years)Experience Level
Full TimeJob Type
UnknownVisa
制药, 医疗保健, 心血管代谢Industries

Requirements

  • 全日制本科学历,临床、药学等相关专业优先。
  • 有外资药企销售经验优先。
  • 有客户开发经验优先。
  • 执行力强,并具有较强的沟通能力与协调能力。
  • 具备良好的职业操守与沟通、协调、组织能力。
  • 工作目标明确,具有良好的问题处理能力。
  • 有韧性,抗压性强。

Responsibilities

  • 完成公司制定的辖区内销售计划。
  • 与当地客户建立良好关系,开拓潜在的医院渠道客户,并对既有的客户进行维护。
  • 准确地向目标客户提供药物的特点、疗效及注意事项等资料信息。
  • 充分了解市场状态,及时向公司反馈竞争状况等市场信息并做出适当建议。
  • 适应团队建设,积极参与和配合跨部门的合作。
  • 为公司树立良好的专业形象,对公司商业秘密做到保密。

Skills

销售推广
客户关系管理
产品宣传
市场分析
沟通协调
团队合作
执行力
客户开发

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters
1876Year Founded
$1,180.1MTotal Funding
IPOCompany Stage
Biotechnology, HealthcareIndustries
10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.
Potential construction delays in Indiana could affect GLP-1 drug production timelines.
Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.
Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.
FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.
Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.
Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI